CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice

ACG promotes Susheel Pillai as the new CEO for Inspection Business

ACG, a leading supplier of fully integrated solutions to the global pharmaceutical and nutraceutical industry, today announced the promotion of Susheel Pillai as the new CEO of ACG Inspection.

Pillai has been associated with ACG for the last 16 years and has been part of the group’s different business units in various capacities. He was previously the Head of India operations as well as Global Sales Head. In his new role, in addition to growing the business of Inspection and Track & Trace Systems, he will also be responsible for introducing new technology, onboarding key talent, and extending ACG Inspection’s footprint across the globe. He will be based out of Mumbai. 

With close to 30 years of a proven track record of managing international business, he has been closely involved in designing and implementing transformational initiatives of the group, executing core business development strategies, building sales organisations across the globe as well as developing emerging leaders.    He takes over from Ettore Cucchetti, who has decided to move back to his home country following five successful years at ACG. 

Commenting on the appointment, Karan Singh, MD, ACG, said: “Susheel has played an instrumental role in developing and expanding the ACG Inspections portfolio. He is the perfect fit for the exciting and challenging role, as the focus begins to shift towards Industry 4.0.”  

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026